Can family physicians have a role in eradication of hepatitis c infection?
Journal
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
ISSN: 2148-5607
Titre abrégé: Turk J Gastroenterol
Pays: Turkey
ID NLM: 9515841
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
entrez:
11
6
2020
pubmed:
11
6
2020
medline:
9
10
2021
Statut:
ppublish
Résumé
Hepatitis C Virus (HCV) infection is an important global public health problem. The application of screening programs is important for the elimination of HCV in addition to DAA therapies. The aim of this study was to measure the knowledge, attitudes and behaviours of family physicians, who are important in screening programs for the diagnosis, natural history, and treatment of HCV infection. This cross-sectional study aimed to measure the knowledge levels in respect of HCV screening, diagnosis, natural history and treatment, of family physicians working nationwide in Turkey, through a survey. The most common reason to perform an anti-HCV test stated by 70.9% (n:420) of the participants was the mandatory screening program before marriage. Of the participants included in the study, 29.6% (n=175) had encountered anti-HCV test positivity at least once within the last year, and of these, 15.4% (n=27) had no knowledge of whether the patient went to a higher level center for further diagnosis, while 58.9% (n=103) did not know the disease stage. In response to questions about current drug options for hepatitis C infection, 14.5% were aware of DAA and 34.8% of participitant reported interferon+ ribavirin. Family physicians have gaps in their knowledge of the screening, natural history and treatment of HCV infection. The results of this study show that HCV training plans for family physicians should cover all aspects of the infection, and emphasize the necessity for the establishment of guideline-based screening recommendations.
Sections du résumé
BACKGROUND/AIMS
Hepatitis C Virus (HCV) infection is an important global public health problem. The application of screening programs is important for the elimination of HCV in addition to DAA therapies. The aim of this study was to measure the knowledge, attitudes and behaviours of family physicians, who are important in screening programs for the diagnosis, natural history, and treatment of HCV infection.
MATERIALS AND METHODS
This cross-sectional study aimed to measure the knowledge levels in respect of HCV screening, diagnosis, natural history and treatment, of family physicians working nationwide in Turkey, through a survey.
RESULTS
The most common reason to perform an anti-HCV test stated by 70.9% (n:420) of the participants was the mandatory screening program before marriage. Of the participants included in the study, 29.6% (n=175) had encountered anti-HCV test positivity at least once within the last year, and of these, 15.4% (n=27) had no knowledge of whether the patient went to a higher level center for further diagnosis, while 58.9% (n=103) did not know the disease stage. In response to questions about current drug options for hepatitis C infection, 14.5% were aware of DAA and 34.8% of participitant reported interferon+ ribavirin.
CONCLUSION
Family physicians have gaps in their knowledge of the screening, natural history and treatment of HCV infection. The results of this study show that HCV training plans for family physicians should cover all aspects of the infection, and emphasize the necessity for the establishment of guideline-based screening recommendations.
Identifiants
pubmed: 32519959
doi: 10.5152/tjg.2020.19913
pmc: PMC7289162
doi:
Substances chimiques
Antiviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
393-399Références
J Hepatol. 2014 Nov;61(1 Suppl):S45-57
pubmed: 25086286
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362-5
pubmed: 23657112
J Community Med Health Educ. 2016 Oct;6(5):
pubmed: 28083156
J Viral Hepat. 2001 Sep;8(5):377-83
pubmed: 11555196
MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32
pubmed: 22895429
Clin Infect Dis. 2013 Jan;56(1):40-50
pubmed: 22990852
Clin Microbiol Infect. 2015 Nov;21(11):1020-6
pubmed: 26163105
Fam Med. 2005 Oct;37(9):644-9
pubmed: 16193428
J Gastroenterol Hepatol. 2002 Mar;17(3):295-300
pubmed: 11982700
Dig Dis Sci. 2007 Oct;52(10):2550-6
pubmed: 17406823
Lancet Infect Dis. 2016 Sep;16(9):e196-e201
pubmed: 27421993
J Viral Hepat. 2014 May;21 Suppl 1:34-59
pubmed: 24713005
N Engl J Med. 2013 May 16;368(20):1859-61
pubmed: 23675657
World J Hepatol. 2018 Feb 27;10(2):319-328
pubmed: 29527267
J Viral Hepat. 2014 May;21 Suppl 1:60-89
pubmed: 24713006
J Hepatol. 2014 Nov;61(1 Suppl):S58-68
pubmed: 25443346
Clin Microbiol Infect. 2016 Oct;22(10):833-838
pubmed: 27521803
Clin Liver Dis (Hoboken). 2014 Aug 25;4(2):31-34
pubmed: 30992916